Immunitybio (IBRX) had the highest return in April 2024 by a large-cap US stock, returning 49.3%.

ASSET	MONTH	% RETURN
Immunitybio (IBRX)	April 2024	49.35%
Regencell Bioscience (RGC)	April 2024	38.01%
Koninklijke Philips NV ADR (PHG)	April 2024	32.48%
Coupang LLC (CPNG)	April 2024	26.19%
Carpenter Technology (CRS)	April 2024	20.13%
Pan American Silver (PAAS)	April 2024	19.2%
Sea (SE)	April 2024	17.13%
Astera Labs (ALAB)	April 2024	16.72%
Futu (FUTU)	April 2024	16.55%
Allegheny Technologies (ATI)	April 2024	16.4%
Revolution Medicines (RVMD)	April 2024	16.21%
GE Aerospace (GE)	April 2024	15.67%
Antero Resources (AR)	April 2024	15.33%
Petroleo Brasileiro Petrobras SA ADR (PBR)	April 2024	14.42%
Vertiv (VRT)	April 2024	13.3%
Natwest (NWG)	April 2024	13.07%
EchoStar (SATS)	April 2024	12.21%
Grab (GRAB)	April 2024	11.82%
Ke Holdings (BEKE)	April 2024	11.67%
Tencent Music Entertainment (TME)	April 2024	11.46%
HSBC Holdings PLC ADR (HSBC)	April 2024	10.69%
Westinghouse Air Brake Technologies (WAB)	April 2024	10.64%
YPF Sociedad Anonima (YPF)	April 2024	10.52%
Hasbro (HAS)	April 2024	10.26%
Coeur Mining (CDE)	April 2024	10.24%

Large-cap stocks are treated as having a market cap of $10B+.